These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12185466)

  • 21. [Principles of treating hypertension patients with diuretics].
    Nekrasova AA
    Ter Arkh; 1986; 58(1):116-20. PubMed ID: 3961683
    [No Abstract]   [Full Text] [Related]  

  • 22. Quiz Page October 2016: Severe Hypokalemia, Metabolic Alkalosis, and Malignancy.
    George JC; Vedamurthy D; Bermudez M; Kennedy JW
    Am J Kidney Dis; 2016 Oct; 68(4):A17-A19. PubMed ID: 27664476
    [No Abstract]   [Full Text] [Related]  

  • 23. Distinction between Liddle syndrome and apparent mineralocorticoid excess.
    Monnens L; Levtchenko E
    Pediatr Nephrol; 2004 Jan; 19(1):118-9. PubMed ID: 14625721
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liddle's syndrome: a 14-year follow-up of the youngest diagnosed case.
    Vania A; Tucciarone L; Mazzeo D; Capodaglio PF; Cugini P
    Pediatr Nephrol; 1997 Feb; 11(1):7-11. PubMed ID: 9035163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liddle syndrome: Pathogenesis, pathophysiology, and therapy].
    Ohta A; Sasaki S
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():513-6. PubMed ID: 16523945
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic idiopathic hypokalemia with hyperkaliuria in a very young infant. (Bioclinical and histological study)].
    Bodin G; Rival JM; Gillot F
    Ann Pediatr (Paris); 1969 Nov; 16(11):665-73. PubMed ID: 4312447
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases].
    Noblins M; Kleinknecht D; Dommergues JP; Nazaret C; Garay RP; Jullien M; Guillot M; Fries D; Charpentier B
    Arch Fr Pediatr; 1992 Oct; 49(8):685-91. PubMed ID: 1288451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of juvenile arterial hypertension associated with hypokalemia and low aldosterone secretion (Liddle syndrome)].
    Veyrat R; Grandchamp A; Bierans de Haan B; Zanchetti A; Muller AF
    Schweiz Med Wochenschr; 1968 May; 98(19):725-6. PubMed ID: 5700759
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypokalemic alkalosis, hyperreninemia, aldosteronism, normal blood pressure and normal juxtaglomerular apparatus--a new syndrome of renal alkalosis.
    Barakat AY; Francis YK; Mufarrij AA
    Int J Pediatr Nephrol; 1986; 7(2):99-100. PubMed ID: 3522459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 34. Amiloride hydrochloride combined with hydrochlorothiazide in the control of hypertension and plasma potassium levels.
    Antcliff AC; Hamilton M; Beevers DG; Harpur JE
    Br J Clin Pract; 1972 Sep; 26(9):413-6. PubMed ID: 5080334
    [No Abstract]   [Full Text] [Related]  

  • 35. Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
    Kinoshita H; Okabayashi M; Kaneko M; Yasuda M; Abe K; Machida A; Ohkubo T; Kamata T; Yakushiji F
    J Altern Complement Med; 2009 Apr; 15(4):439-43. PubMed ID: 19388868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypokalemia, hypomagnesemia, and alkalosis: a rose is a rose--or is it?
    Gitelman HJ
    J Pediatr; 1992 Jan; 120(1):79-80. PubMed ID: 1731028
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome.
    Freundlich M; Ludwig M
    Pediatr Nephrol; 2005 Apr; 20(4):512-5. PubMed ID: 15690192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gitelman syndrome as a cause of psychomotor retardation in a toddler.
    Skalova S; Neuman D; Lnenicka P; Stekrova J
    Arab J Nephrol Transplant; 2013 Jan; 6(1):37-9. PubMed ID: 23282232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary aldosteronism in pregnancy.
    Krysiak R; Samborek M; Stojko R
    Acta Clin Belg; 2012; 67(2):130-4. PubMed ID: 22712170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.